Joan Morris
Children's Hospital of Orange County(US)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Bone mass in healthy children: measurement with quantitative DXA.(1991)325 cited
- → Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia(2021)316 cited
- → Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study(2021)89 cited
- → Sweet's Syndrome as an Initial Manifestation of Pediatric Human Immunodeficiency Virus Infection(1999)47 cited
- → Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents(2020)43 cited
- → Properties of anti-Lyb-2-mediated B-cell activation and the relationship between Lyb-2 molecules and receptors for B-cell stimulatory factor-1 on murine B lymphocytes(1988)35 cited
- → Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia(2022)26 cited
- → Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma(2019)24 cited
- → Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia(2020)23 cited
- → Blinatumomab Alternating With Low-Intensity Chemotherapy (CT) Treatment for Older Adults With Newly Diagnosed Philadelphia (Ph)-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) is Well Tolerated and Efficacious: Safety Run-In Results for the Phase 3 Randomized Controlled Golden Gate Study(2022)22 cited